Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–34 of 10 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Refractory Schizophrenia Clear all

Conditions: Schizophrenia, Auditory Hallucination, Treatment-resistant Schizophrenia
Interventions: stg-rt-fMRI-Neurofeeback, sham-rt-fMRI-Neurofeedback; Other
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 18 Years to 55 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Brockton, Massachusetts

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: quetiapine; Drug
Lead sponsor: Manhattan Psychiatric Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 2
States / cities: New York, New York • Orangeburg, New York

Conditions: Schizophrenia
Interventions: 1 Hz rTMS, 10 Hz rTMS; Device
Lead sponsor: Seton Healthcare Family; Other
Eligibility: 18 Years to 80 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Childhood Onset Psychotic Disorders, Schizophrenia, Psychosis, Mental Disorders
Interventions: Electrical Polarization; Behavioral
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 10 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Refractory Schizophrenia
Interventions: NaBen®, Placebo; Drug · Other
Lead sponsor: SyneuRx International (Taiwan) Corp; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 287 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Schizophrenia
Interventions: Risperidone, Olanzapine, Lu AF35700; Drug
Lead sponsor: H. Lundbeck A/S; Industry
Eligibility: 18 Years and older
Enrollment: 1,098 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 49
States / cities: Bellflower, California • Cerritos, California • Costa Mesa, California + 39 more

Conditions: Schizophrenia
Interventions: Clozapine, Olanzapine; Drug
Lead sponsor: Harvard Medical School (HMS and HSDM); Other
Eligibility: 20 Years to 60 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2002
U.S. locations: 1
States / cities: Jamaica Plain, Massachusetts

Conditions: Schizophrenia
Interventions: Clozapine, Chlorpromazine; Drug
Lead sponsor: Harvard Medical School (HMS and HSDM); Other
Eligibility: 19 Years to 60 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 2002
U.S. locations: 1
States / cities: Jamaica Plain, Massachusetts

Conditions: Schizophrenia
Interventions: Olanzapine, Clozapine; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 10 Years to 18 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 3
States / cities: Dix Hills, New York • Glen Oaks, New York • The Bronx, New York

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Minocycline; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Atlanta, Georgia